MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Bio-Rad Laboratories Inc

Geschlossen

BrancheGesundheitswesen

246.6 -1.32

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

243.55

Max

251.08

Schlüsselkennzahlen

By Trading Economics

Einkommen

780M

64M

Verkäufe

-82M

585M

EPS

2.54

Gewinnspanne

10.933

Angestellte

7,700

EBITDA

75M

134M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+29.38% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

302M

6.8B

Vorheriger Eröffnungskurs

247.92

Vorheriger Schlusskurs

246.6

Nachrichtenstimmung

By Acuity

50%

50%

169 / 376 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Juli 2025, 23:34 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

17. Juli 2025, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17. Juli 2025, 21:04 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

17. Juli 2025, 23:43 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

17. Juli 2025, 23:42 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

17. Juli 2025, 22:47 UTC

Akquisitionen, Fusionen, Übernahmen

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

17. Juli 2025, 22:46 UTC

Akquisitionen, Fusionen, Übernahmen

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

17. Juli 2025, 22:46 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

17. Juli 2025, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

17. Juli 2025, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

17. Juli 2025, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17. Juli 2025, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17. Juli 2025, 22:30 UTC

Market Talk
Ergebnisse

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

17. Juli 2025, 22:20 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

17. Juli 2025, 22:20 UTC

Market Talk
Ergebnisse

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

17. Juli 2025, 22:04 UTC

Market Talk
Ergebnisse

Netflix Redesign Done to Match Current Capabilities -- Market Talk

17. Juli 2025, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

17. Juli 2025, 21:58 UTC

Market Talk
Ergebnisse

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

17. Juli 2025, 21:57 UTC

Ergebnisse

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17. Juli 2025, 21:47 UTC

Ergebnisse

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

17. Juli 2025, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Juli 2025, 21:45 UTC

Market Talk

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17. Juli 2025, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

17. Juli 2025, 21:22 UTC

Akquisitionen, Fusionen, Übernahmen

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17. Juli 2025, 21:05 UTC

Ergebnisse

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17. Juli 2025, 21:04 UTC

Akquisitionen, Fusionen, Übernahmen

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

17. Juli 2025, 21:02 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17. Juli 2025, 20:59 UTC

Akquisitionen, Fusionen, Übernahmen

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17. Juli 2025, 20:50 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

17. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Bio-Rad Laboratories Inc Prognose

Kursziel

By TipRanks

29.38% Vorteil

12-Monats-Prognose

Durchschnitt 323 USD  29.38%

Hoch 387 USD

Tief 245 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bio-Rad Laboratories Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

3

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

229.835 / 235.8095Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

169 / 376 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.